Latest news with #INR1
Business Insider
2 days ago
- Business
- Business Insider
Morgan Stanley Keeps Their Hold Rating on Infosys Limited (INFY)
Morgan Stanley analyst Gaurav Rateria maintained a Hold rating on Infosys Limited (INFY – Research Report) today and set a price target of INR1,670.00. The company's shares closed today at INR1,632.90. Confident Investing Starts Here: Rateria covers the Technology sector, focusing on stocks such as Infosys Limited, Tata Consultancy Services Limited, and Tech Mahindra Limited. According to TipRanks, Rateria has an average return of 21.7% and a 54.55% success rate on recommended stocks. Infosys Limited has an analyst consensus of Moderate Buy, with a price target consensus of INR1,845.06. The company has a one-year high of INR2,006.80 and a one-year low of INR1,307.10. Currently, Infosys Limited has an average volume of 346.7K. Based on the recent corporate insider activity of 94 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of INFY in relation to earlier this year.
Economic Times
4 days ago
- Science
- Economic Times
Cosmic fortress
Why do we exist at all? Why does life flourish on this tiny blue planet suspended in vastness of space? According to a video by the science channel Cosmoknowledge, our existence is not just a random miracle - it is protected and sustained by a remarkable set of cosmic forces quietly working in video says that the first of these is the Moon. It orchestrates the tides, influencing life in our oceans. And it silently takes the blow for us, bearing the brunt of countless asteroid strikes that might otherwise have threatened life here. Further out in the Solar System sits Jupiter, our planetary bodyguard. Massive and majestic, Jupiter's powerful gravity acts as a shield, drawing in or deflecting space debris and rogue asteroids. Without it, Earth could face up to 10,000 times more collisions - any one of which might wipe out life in a heartbeat. Then there is the Sun, the life-giver. Beyond its warmth and light, it generates the heliosphere - a vast, invisible bubble that extends well past Pluto. This bubble deflects deadly cosmic radiation, protecting not just Earth but the entire Solar System. We are wrapped in its embrace, sheltered from the galaxy's harshest still, Earth itself is doing its part. Our magnetic field, always in motion, shields us from solar radiation that could strip away the atmosphere. The ozone layer, too, guards us against ultraviolet of these layers - lunar, planetary, solar, magnetic and atmospheric - functions like a rung in a cosmic ladder, holding life aloft. If any one of them were missing or failed in their purpose, we might not be here to contemplate their presence. The ancient seers taught us to look not just outward but inward - to see the universe as not separate from us but intimately woven into our very existence. We are not alone; we are part of a delicate, celestial balance - living in a fortress of light, motion and grace. (Disclaimer: The opinions expressed in this column are that of the writer. The facts and opinions expressed here do not reflect the views of Elevate your knowledge and leadership skills at a cost cheaper than your daily tea. Worrying cracks hiding behind MG Motor's own 'house of Windsor' Is India ready to hit the aspirational 8% growth mark? INR1,300 crore loans for INR100? Stamp duty notice to ArcelorMittal, banks. Why failed small businessmen die by suicide when those behind big blow-ups bounce back? Stock Radar: Falling trendline breakout on daily and weekly charts likely to push stock to record highs; check target & stop loss Handle volatility in conventional & unconventional ways: Capital gains & dividend yield. 6 stocks with dividend yield of 4-8%; return of over 22% Keys to wealth creation: Strong balance sheet & patience. 5 large-cap stocks from different sectors with upside potential of up to 38% Defence stocks: Black & white, and many shades of grey. 10 stocks with an upside potential of up to 30%
Time of India
13-06-2025
- Business
- Time of India
INR1,300 crore loans for INR100? Stamp duty notice to ArcelorMittal, banks.
INR1,300 crore loans for INR100? Stamp duty notice to ArcelorMittal, banks. Getty Images Synopsis ArcelorMittal India has been called for enquiry this month over allegations of stamp duty irregularities. Creditors of KSS Petron, a group company, have alleged irregularities in stamp duty payment in assignment of loans in the run up to its acquisition of Essar Steel under the IBC. By N SUNDARESHA SUBRAMANIAN 4 Mins Read, Jun 13, 2025, 05:55 PM IST SHARE THIS NEWS Close Font Size Abc Small Small Abc Normal Normal Abc Large Close A stamp duty dispute has erupted around a 2018 financial transaction involving global steel giant ArcelorMittal and a group of banks. The Collector of Stamps of Mumbai under Maharashtra government has issued a notice for enquiry over alleged irregularities in payment of stamp duty on a loan assignment transaction dating back to 2018. In October 2018, a group of lenders of KSS Petron (KSSPL) led by the State bank of India (SBI) had assigned dues
Business Insider
08-06-2025
- Business
- Business Insider
Citi Sticks to Their Buy Rating for PB Fintech Limited (POLICYBZR)
Citi analyst Dipanjan Ghosh maintained a Buy rating on PB Fintech Limited (POLICYBZR – Research Report) on June 5 and set a price target of INR2,185.00. The company's shares closed last Friday at INR1,916.70. Confident Investing Starts Here: According to TipRanks, Ghosh is a 3-star analyst with an average return of 9.0% and a 72.22% success rate. Ghosh covers the Financial sector, focusing on stocks such as Go Digit General Insurance Limited, ICICI Lombard General Insurance Co. Ltd., and ICICI Prudential Life Insurance Co. Ltd.. In addition to Citi, PB Fintech Limited also received a Buy from Investec's Nidhesh Jain in a report issued on May 25. However, on May 28, UBS maintained a Sell rating on PB Fintech Limited (NSE: POLICYBZR).
Yahoo
07-06-2025
- Business
- Yahoo
HSBC Upgrades Dr. Reddy's Laboratories Limited (RDY) to Buy from Hold
On June 5, HSBC upgraded Dr. Reddy's Laboratories Limited (NYSE:RDY) from Buy to Hold, raising the price target to INR1,445 from INR1,235, citing an optimistic outlook for the company in terms of earnings potential and solid market standing. A worker at a biopharmaceutical facility packaging an active pharmaceutical ingredient. HSBC's updated estimates for FY2026 to FY2028 take into account the shifting market tide for semaglutide and gRevlimid. The analysts are waiting for semaglutide to be introduced in Canada, Brazil, and India at the beginning of FY2027, which is a greater leap from their prior hypothesis of a launch only in Canada by Q4 of FY2026. The analysts revised their FY2026 sales figures for Dr. Reddy's Laboratories Limited (NYSE:RDY)'s gRevlimid, noting the growing competition. The adjustment includes a 5.1% decrease in the EPS estimate for FY2026, while the EPS forecast for FY2027 and FY2028 grew by 12% to 13%. According to HSBC analysts, the expected surge in semaglutide sales will strengthen Dr. Reddy's earnings. HSBC assigned a new price target for RDY's American Depositary Receipts (ADR) as well, raising it from $14.44 to $16.90. Dr. Reddy's Laboratories Limited (NYSE:RDY) is a global pharma company based in Hyderabad, India, that makes both branded and generic medicines for a wide range of health conditions. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. While we acknowledge the potential of RDY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
